Introduction
Addressing an Unmet Need
Product Info
Pharmacological class
Clinical Studies
Menopausal Symptoms
FemarelleŽ & Bone Loss
    . Effect on Bone Mineral Density
    . Mechanism of action in the bone
    . Skeletal tissue & the uterus
    . Histology of skeletal tissue
FemarelleŽ & Breast Tissue
FemarelleŽ as a SERM
FAQ
Manufacturing Procedure

   
Pharmacological class

The uniqueness of Femarelle® derives from its origin as a plant-based SERM that targets specific tissue sites.

Femarelle® relieves menopausal symptoms and increases bone mineral density, while having no effect on the uterus or on breast tissue. This tissue-selective mechanism of activity has been demonstrated and confirmed in clinical and pre-clinical studies.

Femarelle® represents a new horizon in menopause management therapies, providing a safe and effective solution for the relief of menopausal symptoms and bone health.

Femarelle’s Mechanism of Action - SERM

 

 
Home   Site Map   Disclamer © Se-cure Pharmaceuticals Ltd.